Drawing for NAXREDY

USPTO serial 88752698

NAXREDY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MEYERS, MORGAN LAURA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NAXREDY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gene K. Park

Gene K. Park Morgan, Lewis & Bockius LLPOne Market, Spear Street TowerSan Francisco, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations, namely, narcotic antagonists; Pharmaceutical preparations, namely, opioid antagonists; Syringes sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Syringes sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Syringes sold filled with narcotic antagonists; Syringes sold filled with opioid antagonists; Injectors sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Injectors sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Injectors sold filled with narcotic antagonists; Injectors sold filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose and addiction; Injectable pharmaceuticals for use in the treatment of substance abuse disorders, addiction, and overdose; Injectable pharmaceuticals, namely, narcotic antagonists; Injectable pharmaceuticals, namely, opioid antagonistsACTIVE—
010Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 8, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 8, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 7, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 6, 2023EX5GSOU EXTENSION 5 GRANTED—
Jun 2, 2023EXT5SOU EXTENSION 5 FILED—
Jun 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 22, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 21, 2023EX4GSOU EXTENSION 4 GRANTED—
Apr 20, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 2, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Mar 1, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Mar 1, 2023PETGPETITION TO REVIVE-GRANTED—
Mar 1, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Mar 1, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 1, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 1, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 1, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 11, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 9, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 9, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2022EXT4SOU EXTENSION 4 FILED—
May 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 10, 2022EX3GSOU EXTENSION 3 GRANTED—
May 10, 2022EXT3SOU EXTENSION 3 FILED—
May 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 1, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2021EX2GSOU EXTENSION 2 GRANTED—
Nov 29, 2021EXT2SOU EXTENSION 2 FILED—
Nov 29, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Apr 22, 2021EXT1SOU EXTENSION 1 FILED—
Apr 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 8, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 13, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 13, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2020ALIEASSIGNED TO LIE—
Aug 14, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2020DOCKASSIGNED TO EXAMINER—
Jan 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance